The Intersection of Menopause and Glaucoma
Health LibraryLatest Research in Women's Health
The Intersection of Menopause and Glaucoma

Recent research spearheaded by Amber Douglass, Michael Dattilo, and Andrew J. Feola delves into the potent correlation between menopause and the increased risk of glaucoma, offering profound insights into the role of estrogen depletion on ocular health. This detailed analysis explores the critical findings of their review and underscores the implications for understanding glaucoma’s pathophysiology.

Estrogen’s Protective Role in Ocular Health

The review extensively discusses estrogen's significant protective mechanisms within the eye. Estrogen is shown to contribute to the health of retinal ganglion cells and the structural integrity of the optic nerve. During menopause, the abrupt decrease in estrogen levels could lead to increased vulnerability in ocular tissues, predisposing individuals to glaucoma. This relationship is highlighted by observed changes in intraocular pressure (IOP) and aqueous outflow resistance, which are well-documented risk factors for glaucoma.

Clinical Evidence Linking Menopause and Glaucoma

One of the critical points discussed involves epidemiological data that suggest a higher prevalence of glaucoma in postmenopausal women. The review references several studies where menopause has been associated with alterations in IOP, a key player in glaucoma development. Notably, menopausal women often exhibit a rise in IOP compared to premenopausal women, underscoring the impact of hormonal changes on ocular dynamics.

Insights from Preclinical Models

Preclinical studies have been invaluable in elucidating how estrogen directly influences ocular physiology. The review covers experiments indicating that estrogen supplementation can reduce IOP and protect against retinal ganglion cell death in animal models. These findings suggest that estrogen not only maintains ocular pressure within healthy limits but also offers neuroprotective effects that could be crucial in slowing the progression of glaucoma.

Estrogen, Ocular Biomechanics, and Glaucoma Risk

An interesting aspect of the review is the discussion on how estrogen impacts the biomechanical properties of the eye. Studies have shown that estrogen affects the stiffness and responsiveness of ocular tissues to mechanical stress, which in turn influences IOP regulation and susceptibility to optic nerve damage. The depletion of estrogen during menopause might therefore result in biomechanical alterations that predispose the eye to glaucomatous changes.


The review by Douglass, Dattilo, and Feola provides compelling evidence that menopause acts as a significant risk factor for glaucoma, primarily through the effects of estrogen withdrawal on ocular physiology. These findings not only enhance our understanding of glaucoma’s etiology in women but also pave the way for potential therapeutic interventions that could mitigate this risk by targeting the hormonal changes associated with menopause.

  • Evidence for Menopause as a Sex-Specific Risk Factor for Glaucoma; Cellular and Molecular Neurobiology, 2023
1.Estrogen’s Protective Role in Ocular Health
2.Clinical Evidence Linking Menopause and Glaucoma
3.Insights from Preclinical Models
4.Estrogen, Ocular Biomechanics, and Glaucoma Risk